Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

Continuous, comprehensive and crucial care: The role of the CNS in the metastatic castration-resistant prostate cancer patient pathway

British Journal of Nursing ◽

10.12968/bjon.2018.27.sup4b.s1 ◽

2018 ◽

Vol 27 (Sup4b) ◽

pp. S1-S8 ◽

Cited By ~ 2

Author(s):

Vanessa Basketter ◽

Miranda Benney ◽

Louise Causer ◽

Louisa Fleure ◽

David Hames ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Prostate Cancer Patient ◽

Patient Pathway ◽

Abstract PO-129: Using the castration resistant prostate cancer patient-derived xenograft (PDX) tumor model to identify mRNA/miRNA biomarkers which distinguish abiraterone treatment responders and non-responders

10.1158/1538-7445.tumhet2020-po-129 ◽

2020 ◽

Author(s):

Bin Ouyang ◽

Dan Song ◽

Jacek Biesiada ◽

Yan Ren ◽

Mario Medvedovic ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Prostate Cancer Patient ◽

Tumor Model ◽

Castration Resistant ◽

Patient Derived Xenograft

Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000180 ◽

2015 ◽

Vol 26 (2) ◽

pp. 236-239 ◽

Cited By ~ 3

Author(s):

Giuseppe Di Lorenzo ◽

Carlo Buonerba ◽

Sabino de Placido

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Progressive Disease ◽

Prostate Cancer Patient ◽

An Unusual Prostate-Specific Antigen Decrease in an Advanced Castration-Resistant Prostate Cancer Patient with Intracerebral Hemorrhage Subsequently Treated with Luteinizing Hormone-Releasing Hormone Antagonist

Case Reports in Nephrology and Urology ◽

10.1159/000357668 ◽

2013 ◽

Vol 3 (2) ◽

pp. 136-138

Author(s):

Kouji Izumi ◽

Atsushi Mizokami ◽

Mikio Namiki

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Cancer Patient ◽

Intracerebral Hemorrhage ◽

Prostate Specific Antigen ◽

Prostate Cancer Patient ◽

Specific Antigen ◽

Luteinizing Hormone Releasing Hormone ◽

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations

OncoTargets and Therapy ◽

10.2147/ott.s103532 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4089-4098 ◽

Cited By ~ 5

Author(s):

Sheel Patel ◽

Jean Hoffman-Censits

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Patient Selection ◽

Prostate Cancer Patient ◽

Abstract 4815: A novel AR splice variant identified in circulating tumor cells from castration-resistant prostate cancer patient blood as a potentially prognostic biomarker

10.1158/1538-7445.am2014-4815 ◽

2014 ◽

Author(s):

Zhigang Kang ◽

Yunkai Yu ◽

Liang Cao ◽

Paul S. Meltzer ◽

Yuelin Zhu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Splice Variant ◽

Prostate Cancer Patient ◽

Prognostic Biomarker ◽

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(13)70424-8 ◽

2013 ◽

Vol 14 (12) ◽

pp. 1193-1199 ◽

Cited By ~ 97

Author(s):

Ethan Basch ◽

Karen Autio ◽

Charles J Ryan ◽

Peter Mulders ◽

Neal Shore ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Prostate Cancer Patient ◽

Patient Reported Outcome ◽

Abiraterone Acetate ◽

Phase 3 ◽

Castration Resistant ◽

Patient Reported

Whole-Body 177Lu–Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000003167 ◽

2020 ◽

Vol 45 (10) ◽

pp. 805-807

Author(s):

Emran Askari ◽

Soroush Zarehparvar Moghadam ◽

Ghasemali Divband ◽

Kamran Aryana

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Prostate Cancer Patient ◽

Whole Body ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant ◽

Scan Pattern ◽

Specific Membrane

Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain

Value in Health ◽

10.1016/j.jval.2013.08.476 ◽

2013 ◽

Vol 16 (7) ◽

pp. A405

Author(s):

J. Morote ◽

J.M. Cozar ◽

I. Duran ◽

F. Gomez Veiga ◽

L. Leon ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Patient Management ◽

Prostate Cancer Patient ◽

Cost Assessment ◽

Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-019-04623-x ◽

2019 ◽

Vol 47 (8) ◽

pp. 2040-2041 ◽

Cited By ~ 4

Author(s):

Fadi Khreish ◽

Florian Rosar ◽

Clemens Kratochwil ◽

Frederik Lars Giesel ◽

Uwe Haberkorn ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Prostate Cancer Patient ◽

Castration Resistant ◽

Pet Ct